Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine

References

• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 Jun;85(6):638–646. doi:10.1016/S1079-2104(98)90029-4.
   PubMed Web of Science ®Google Scholar
• Kia C, Baldino J, Bell R, Ramji A, Uyeki C, Mazzocca A. Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med 2018 Dec;11(4):566–572. doi:10.1007/s12178-018-9515-y.
   PubMed Web of Science ®Google Scholar
• Giordano S, Romeo M, Di Summa P, Salval A, Lankinen P. A meta-analysis on evidence of platelet-rich plasma for androgenetic alopecia. Int J Trichology 2018 Jan-Feb;10(1):1–10. doi:10.4103/ijt.ijt_74_16.
   PubMedGoogle Scholar
• Rachul C, Rasko JEJ, Caulfield T. Implicit hype? Representations of platelet rich plasma in the news media. PLoS One 2017 Aug 9;12(8):e0182496. doi:10.1371/journal.pone.0182496.
   PubMed Web of Science ®Google Scholar
• Fadadu PP, Mazzola AJ, Hunter CW, Davis TT. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med 2019 Apr 16;44(6):652–659. doi:10.1136/rapm-2018-100356.
   Web of Science ®Google Scholar
• Jones IA, Togashi RC, Thomas Vangsness C Jr. The economics and regulation of prp in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med 2018 Dec;11(4):558–565. doi:10.1007/s12178-018-9514-z.
   PubMed Web of Science ®Google Scholar
• Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, Dornan GJ, Muschler GF, LaPrade RF. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017 Oct 18;99(20):1769–1779. doi:10.2106/JBJS.16.01374.
   PubMed Web of Science ®Google Scholar
• Chu CR, Rodeo S, Bhutani N, Goodrich LR, Huard J, Irrgang J, LaPrade RF, Lattermann C, Lu Y, Mandelbaum B, et al. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 Conference. J Am Acad Orthop Surg 2019 Jan 15;27(2):e50–e63. doi:10.5435/JAAOS-D-18-00305.
   PubMed Web of Science ®Google Scholar
• Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am 2017 May 17;99(10):809–819. doi:10.2106/JBJS.16.00793.
   PubMed Web of Science ®Google Scholar
• Harrison P, Subcommittee on Platelet Physiology. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost 2018 Sep;16(9):1895–1900. doi:10.1111/jth.14223.
   PubMed Web of Science ®Google Scholar
• DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy 2012;28(7):998–1009. doi:10.1016/j.arthro.2012.04.148.
   PubMed Web of Science ®Google Scholar
• Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Current Pharmaceutical Biotechnology 2012;13(7):1185–1195. doi:10.2174/138920112800624283.
   PubMed Web of Science ®Google Scholar
• Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, Bowen JE. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. Pm R 2015 Apr;7(4 Suppl):S53–9. doi:10.1016/j.pmrj.2015.02.005.
   PubMedGoogle Scholar
• Magalon J, Chateau AL, Bertrand B, Louis ML, Silvestre A, Giraudo L, Veran J, Sabatier F. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med 2016 Feb 4;2.
   Google Scholar
• Lana JFSD, Purita J, Paulus C, Huber SC, Rodrigues BL, Rodrigues AA, Santana MH, Madureira JL Jr, Malheiros Luzo ÂC, Belangero WD, et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen Med 2017 Jul;12(5):565–574. doi:10.2217/rme-2017-0042.
   PubMed Web of Science ®Google Scholar
• Kon E, Di Matteo B, Delgado D, Cole BJ, Dorotei A, Dragoo JL, Filardo G, Fortier LA, Giuffrida A, Jo CH, et al. Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opin Biol Ther 2020 Jul 21. doi:10.1080/14712598.2020.1798925.
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9.W64. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004 Nov;114(6):1502–1508.
   PubMed Web of Science ®Google Scholar
• Leitner GC, Gruber R, Neumüller J, Wagner A, Kloimstein P, Hocker P, Kormoczi GF, Buchta C. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang 2006;91(2):135–139. doi:10.1111/j.1423-0410.2006.00815.x.
   PubMed Web of Science ®Google Scholar
• Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 2011;39(2):266–271. doi:10.1177/0363546510387517.
   PubMed Web of Science ®Google Scholar
• Kaux JF, Le Goff C, Seidel L, Péters P, Gothot A, Albert A, Crielaard J-M. Comparative study of five techniques of preparation of platelet-rich plasma. Pathol Biol 2011;59:157–160. doi:10.1016/j.patbio.2009.04.007.
   PubMed Web of Science ®Google Scholar
• Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, Arciero RA, Beitzel K. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012 Feb 15;94(4):308–316. doi:10.2106/JBJS.K.00430.
   PubMed Web of Science ®Google Scholar
• Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, Magalon G, Dignat-Georges F, Sabatier F. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy 2014;30(5):629–638. doi:10.1016/j.arthro.2014.02.020.
   PubMed Web of Science ®Google Scholar
• Atashi F, Jaconi ME, Pittet-Cuénod B, Modarressi A. Autologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion. Tissue Eng Part C Methods 2015 Mar;21(3):253–262. doi:10.1089/ten.tec.2014.0206.
   PubMed Web of Science ®Google Scholar
• Oh JH, Kim W, Park KU, Roh YH. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med 2015 Dec;43(12):3062–3070. doi:10.1177/0363546515608481.
   PubMed Web of Science ®Google Scholar
• Mandle RJ. Research study Comparison of EmCyte GS30-PurePRP® II, EmCyte GS60-PurePRP® II, Arteriocyte MAGELLAN, Stryker REGENKIT®THT, and ECLIPSE PRP. Cambridge, MA: BioSciences Research Associates, Inc; 2016.
   Google Scholar
• Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med 2017 Jan 3;5(1):2325967116675272.
   Web of Science ®Google Scholar
• Degen RM, Bernard JA, Oliver KS, Dines JS. Commercial separation systems designed for preparation of platelet-rich plasma yield differences in cellular composition. Hss J 2017 Feb;13(1):75–80. doi:10.1007/s11420-016-9519-3.
   PubMedGoogle Scholar
• Guillibert C, Charpin C, Raffray M, Benmenni A, Dehaut FX, El Ghobeira G, Giorgi R, Magalon J, Arniaud D. Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective routine care study. Int J Mol Sci 2019 Mar 15;20(6):1327. doi:10.3390/ijms20061327.
   Web of Science ®Google Scholar
• Everts PA, Malanga GA, Paul RV, Rothenberg JB, Stephens N, Mautner KR. Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review. Regen Ther 2019 May;10(11):56–64. doi:10.1016/j.reth.2019.03.009.
   Google Scholar
• Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010 Sep;8(9):1895–1902.
   PubMed Web of Science ®Google Scholar
• Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med 2014 May;42(5):1204–1210. doi:10.1177/0363546514525593.
   PubMed Web of Science ®Google Scholar
• Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med 2020 Apr;17:363546520909397.
   Google Scholar